Clinical trial
Green Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has…
NCT00005828 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00005828 |
|---|---|
| Title | Green Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy |
| Official title | A Phase II Trial of Green Tea Extract in the Treatment of Androgen-Independent Metastatic Prostate Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Dietary Supplement |
| Interventions | green tea extract |
| Enrollment | 54 |
| Start date | Dec 1, 2000 |
| Primary completion | Mar 1, 2003 |
| Completion | Jun 1, 2008 |
| First posted | Apr 20, 2004 |
| Last update posted | Jul 13, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: